Not investment advice. This is a personal learning log. The authors are not SEBI-registered investment advisers or research analysts. Nothing here is a recommendation to buy or sell any security. Intraday levels are published only after the session has closed, as a record of what was tested. The portfolio is simulated, and past results don't predict future ones. Do your own research.

NSE Intraday Candidates — Tue 29 Sep 2026

Levels planned from Mon 28 Sep 2026 EOD only (not live)

1) Confirmation — data used

Session bar date: Mon 28 Sep 2026 (Yahoo Finance India .NS daily bars; Screener.in “28 Sep - close price”).
Index context: Nifty 50 closed 22,780.25 (−1.56% / −360.25); Sensex 72,771.72 (−1.52%). Breadth: 47/50 Nifty down; only DRREDDY, INFY, HDFCLIFE green in Nifty. (Hindu BusinessLine / Upstox / HDFC Sky, 28 Sep 2026.)
Technicals: Yahoo Finance chart API OHLC/volume; 20/50-DMA, RSI(14), 20d RS vs Nifty computed from those closes (script in this folder → eod_tech.json).
Fundamentals: Screener.in consolidated pages fetched 28 Sep 2026 evening IST (figures cited below).
Calendar: Tue 29 Sep 2026 is a normal NSE day. Fri 2 Oct Gandhi Jayanti irrelevant for this run.

Market bias for Tue: risk-off after sharp Mon sell-off — prefer stock-specific RS over index beta; cancel quickly if Nifty gaps lower.

Only 2 names clear both quality (≥~15% ROE/ROCE, liquid large-cap/F&O, manageable debt, no obvious governance red flag) and Mon EOD momentum with a usable ~1% stop. Not forcing a third.

2) Ranked CANDIDATES

1) ZYDUSLIFE (NSE) — PRIMARY

Fundamental (Screener.in, as of Mon 28 close ₹1,215):
ROE 21.2%, ROCE 21.1%; sales 3Y CAGR 16%, profit 5Y CAGR ~19%; mcap ₹1,21,388 Cr; promoter ~75%. Borrowings rose in FY26 (D/E ≈ 0.46 from Screener BS — manageable, watch). No Screener governance checklist red flag.

Technical setup (Mon 28 Sep EOD — Yahoo ZYDUSLIFE.NS):
O 1,210.70 / H 1,228.60 / L 1,201.20 / C 1,215.00 (+0.92%); vol 39.9L vs ~20d avg ~12.5L (~3.2×). Fresh 52W high zone (H 1,228.60). Above rising 20-DMA ~1,148 and rising 50-DMA ~1,139; RSI(14) ~67; 20d RS vs Nifty ~+10.4 pp. USFDA NJ pharmacovigilance inspection NIL observations (Business Standard / ZeeBiz, 28 Sep). Structure: HH breakout / continuation on heavy volume into weak tape.

Field	Level
Limit entry	1,212
Stop (~1%)	1,200
Target (1.5–2× risk)	1,230 – 1,236
R:R	1.5 : 1 to 2.0 : 1

Reason + source: Clean quality + rare green/high-vol RS name on a −1.56% Nifty day; above rising 20/50-DMA; catalyst plus volume confirmation. Yahoo EOD 28 Sep; Screener fundamentals; BS/ZeeBiz news.

Cancel at open: Gap open ≥1,225 (chase past useful limit); open ≤1,200 (stop already gone); or Nifty opens sharply weak and ZYDUS fails to hold 1,205 in first 15–30 min.

2) DIVISLAB (NSE) — SECONDARY

Fundamental (Screener.in, as of Mon 28 close ₹9,550):
ROE 16.5%, ROCE 22.0%; almost debt-free (borrowings negligible); sales 3Y CAGR 11%, TTM sales +16%, TTM profit +29%; mcap ₹2,53,773 Cr; F&O/Nifty Next 50 liquid. Screener notes rich valuation (high P/B) but quality/debt clear the checklist.

Technical setup (Mon 28 Sep EOD — Yahoo DIVISLAB.NS):
O 9,600 / H 9,655 / L 9,473 / C 9,550 (−0.72%); vol 3.8L vs ~20d avg ~4.8L (~0.8× — soft). Still above rising 20-DMA ~9,370 and rising 50-DMA ~8,729; RSI(14) ~64; 20d RS vs Nifty ~+6.7 pp. Structure: orderly pullback inside HH-HL uptrend (held relatively well vs Nifty crash) — volume not confirmatory, hence secondary only.

Field	Level
Limit entry	9,530
Stop (~1%)	9,435
Target (1.5–2× risk)	9,670 – 9,720
R:R	1.5 : 1 to 2.0 : 1

Reason + source: Quality large-cap API name still above rising 20/50 with positive RS after a shallow Mon dip; usable 1% stop under prior-day mid-range. Lower conviction than ZYDUS (red day + sub-avg volume). Yahoo EOD 28 Sep; Screener fundamentals.

Cancel at open: Gap open ≥9,620 (chase); open ≤9,435; or fails 9,470 early with Nifty still selling.

3) REJECTS (considered)

Name	Why rejected (1 line)
DRREDDY	Strong Mon RS (+1.67%, vol ~2.6×) but Screener ROE 11.2% / ROCE 13.0% fail ≥15% quality; TTM profit −43%; results due 23 Oct.
APOLLOHOSP	Quality OK (ROE 21.2% / ROCE 17.4%) but 20/50-DMA not rising; Mon −0.33%, RSI ~51 — prior secondary lost momentum edge.
AUROPHARMA	Above MAs / ok RS but Screener ROE 10.1% / ROCE 12.9% fail quality gate.
MANKIND	ROE 13.1% / ROCE 13.5% fail quality; Mon closed near day low (close_pos ~0.09).
HINDZINC	Still below 20/50-DMA; RSI ~46; prior 52W-low soft tape continues.
OFSS	Deep below 20/50-DMA (~11.5k vs C 10,800); RSI ~36; RS20 ~−8 pp.
BSE	Below falling 20/50-DMA; RSI ~37; weak close_pos.
POLYCAB	Below 20/50-DMA; RSI ~37; closed near day low (−% vs Nifty not enough).
INFY	Green on Mon but below both DMAs, RSI ~31 — oversold bounce not quality-momentum setup.
GLAXO	Green/high vol but day range ~7% (L 2790–H 2987) — no clean ~1% stop.

4) Desk paste (copy-paste ready)

Intraday desk — planned levels from Mon 28 Sep EOD for Tue 29 Sep session (not live)

Market: Nifty 22,780 (−1.56%). Prefer RS names; cancel if index gaps hard lower.

1) ZYDUSLIFE — PRIMARY
Entry 1212 | Stop 1200 | Target 1230–1236 | R:R 1.5–2
ROE 21.2% ROCE 21.1% | Mon C 1215 H 1228.6 vol ~3.2x | above rising 20/50 DMA RSI~67 | USFDA NIL news
Cancel: gap ≥1225 or open ≤1200 or fails 1205 early

2) DIVISLAB — SECONDARY
Entry 9530 | Stop 9435 | Target 9670–9720 | R:R 1.5–2
ROE 16.5% ROCE 22% debt-free | Mon C 9550 (−0.72%) above rising 20/50 RSI~64 RS+ | vol soft ~0.8x
Cancel: gap ≥9620 or open ≤9435 or fails 9470 early

No 3rd name — rest failed quality or Mon technicals (DRREDDY funda, APOLLOHOSP MAs flat, HINDZINC/OFSS/BSE/POLYCAB still weak).
Real Stock Trader sizes / proposes; the owner yes required. No live data.